Applied Genetic Technologies reported $325K in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Alimera Sciences ALIM:US USD 13.6M 1.01M
Biogen BIIB:US USD 2.51B 80.6M
Bluebird Bio BLUE:US USD 71K 1.45M
Celldex Therapeutics CLDX:US USD 407K 244K
Cti Biopharma CTIC:US USD 18.24M 5.91M
Gilead Sciences GILD:US USD 7.04B 782M
Insmed INSM:US USD 67.73M 2.51M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Regeneron Pharmaceuticals REGN:US USD 2.94B 79M
Rigel Pharmaceuticals RIGL:US USD 22.41M 7.41M
Roche Holding ROG:VX CHF 32.3B 207M
Ultragenyx Pharmaceutical RARE:US USD 90.7M 1.36M